OPTUS Pharmaceutical 過去の業績

過去基準チェック /46

OPTUS Pharmaceuticalの収益は年間平均-12.3%の割合で減少していますが、 Medical Equipment業界の収益は年間増加しています。収益は年間17.7% 4.2%割合で増加しています。 OPTUS Pharmaceuticalの自己資本利益率は7.4%であり、純利益率は13.2%です。

主要情報

-12.3%

収益成長率

-10.7%

EPS成長率

Medical Equipment 業界の成長	22.7%
収益成長率	4.2%
株主資本利益率	7.4%
ネット・マージン	13.2%
前回の決算情報	30 Jun 2024

OPTUS Pharmaceutical's (KOSDAQ:131030) Earnings Are Of Questionable Quality

Mar 13

DHP Korea's (KOSDAQ:131030) Problems Go Beyond Weak Profit

Mar 09

Recent updates

Benign Growth For OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030) Underpins Stock's 25% Plummet

Nov 14

Investors Could Be Concerned With OPTUS Pharmaceutical's (KOSDAQ:131030) Returns On Capital

Nov 13

Capital Allocation Trends At OPTUS Pharmaceutical (KOSDAQ:131030) Aren't Ideal

Aug 07

There's Reason For Concern Over OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Massive 28% Price Jump

Jun 27

There's No Escaping OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Muted Earnings Despite A 43% Share Price Rise

Mar 25

DHP Korea Co., Ltd.'s (KOSDAQ:131030) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Feb 10

How Much Did DHP Korea's(KOSDAQ:131030) Shareholders Earn From Share Price Movements Over The Last Five Years?

Jan 12

Should We Be Excited About The Trends Of Returns At DHP Korea (KOSDAQ:131030)?

Dec 08

収支内訳

OPTUS Pharmaceutical の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

KOSDAQ:A131030 収益、費用、利益 ( )KRW Millions
日付	収益	収益	G+A経費	研究開発費
30 Jun 24	77,791	10,248	31,709	1,783
31 Mar 24	74,206	11,114	30,752	1,434
31 Dec 23	72,426	10,760	30,619	1,384
30 Sep 23	67,100	8,004	28,769	1,326
30 Jun 23	63,352	7,557	27,001	1,272
31 Mar 23	60,865	4,845	25,936	1,192
31 Dec 22	58,658	5,012	24,147	1,343
30 Sep 22	57,723	8,119	22,356	1,627
30 Jun 22	57,819	9,130	21,547	1,529
31 Mar 22	57,606	10,242	20,597	1,376
31 Dec 21	57,316	9,892	20,496	1,110
30 Sep 21	54,719	9,358	19,970	742
30 Jun 21	56,109	8,942	21,448	700
31 Mar 21	59,409	12,055	22,489	707
31 Dec 20	60,827	14,405	22,288	822
30 Sep 20	66,327	14,770	23,446	1,302
30 Jun 20	64,733	16,123	21,989	1,327
31 Mar 20	61,917	15,338	20,741	1,289
31 Dec 19	60,441	14,596	20,247	1,148
30 Sep 19	55,404	12,178	18,967	632
30 Jun 19	53,579	11,441	17,786	560
31 Mar 19	51,389	10,526	16,511	694
31 Dec 18	49,625	10,003	15,436	758
30 Sep 18	49,778	10,549	14,743	802
30 Jun 18	50,484	11,423	14,658	819
31 Mar 18	49,914	12,120	14,415	677
31 Dec 17	49,808	12,879	14,284	552
30 Sep 17	50,312	14,455	14,046	584
30 Jun 17	48,760	13,582	13,345	884
31 Mar 17	47,351	12,787	12,867	1,097
31 Dec 16	44,720	11,496	12,379	1,248
30 Sep 16	42,229	10,723	12,187	1,552
30 Jun 16	41,558	10,854	11,658	2,095
31 Mar 16	40,258	10,499	11,175	2,230
31 Dec 15	38,559	10,298	10,746	2,024
30 Sep 15	38,020	10,674	10,477	1,476
30 Jun 15	35,466	10,160	10,401	519
31 Mar 15	33,769	9,800	10,309	95
31 Dec 14	32,566	9,519	10,111	88
30 Sep 14	37,206	5,353	11,516	81
30 Jun 14	28,662	2,832	8,951	76
31 Mar 14	27,685	2,136	8,570	74
31 Dec 13	26,850	1,425	8,050	69

質の高い収益: A131030は高品質の収益を持っています。

利益率の向上: A131030の現在の純利益率 (13.2%)は、昨年(11.9%)よりも高くなっています。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: A131030の収益は過去 5 年間で年間12.3%減少しました。

成長の加速: A131030の過去 1 年間の収益成長率 ( 35.6% ) は、5 年間の平均 ( 年間-12.3%を上回っています。

収益対業界: A131030の過去 1 年間の収益成長率 ( 35.6% ) はMedical Equipment業界1.6%を上回りました。

株主資本利益率

高いROE: A131030の自己資本利益率 ( 7.4% ) は低いとみなされます。

OPTUS Pharmaceutical 過去の業績

過去 基準チェック /46

主要情報

最近の業績更新

OPTUS Pharmaceutical's (KOSDAQ:131030) Earnings Are Of Questionable Quality

DHP Korea's (KOSDAQ:131030) Problems Go Beyond Weak Profit

Recent updates

Benign Growth For OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030) Underpins Stock's 25% Plummet

Investor sentiment deteriorates as stock falls 15%

Investors Could Be Concerned With OPTUS Pharmaceutical's (KOSDAQ:131030) Returns On Capital

Capital Allocation Trends At OPTUS Pharmaceutical (KOSDAQ:131030) Aren't Ideal

Investor sentiment deteriorates as stock falls 17%

Investor sentiment improves as stock rises 16%

There's Reason For Concern Over OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Massive 28% Price Jump

Investor sentiment improves as stock rises 21%

New major risk - Share price stability

Investor sentiment deteriorates as stock falls 17%

There's No Escaping OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Muted Earnings Despite A 43% Share Price Rise

Investor sentiment improves as stock rises 28%

New minor risk - Share price stability

OPTUS Pharmaceutical's (KOSDAQ:131030) Earnings Are Of Questionable Quality

New minor risk - Earnings quality

Inaugural dividend of ₩100.00 per share

Investor sentiment improves as stock rises 15%

Inaugural dividend of ₩100.00 per share

Inaugural dividend of ₩100.00 per share

The Returns On Capital At DHP Korea (KOSDAQ:131030) Don't Inspire Confidence

New 90-day low: ₩7,710

DHP Korea's (KOSDAQ:131030) Problems Go Beyond Weak Profit

DHP Korea Co., Ltd., Annual General Meeting, Mar 22, 2021

DHP Korea Co., Ltd.'s (KOSDAQ:131030) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

How Much Did DHP Korea's(KOSDAQ:131030) Shareholders Earn From Share Price Movements Over The Last Five Years?

New 90-day high: ₩8,770

Should We Be Excited About The Trends Of Returns At DHP Korea (KOSDAQ:131030)?

New 90-day low: ₩7,510

収支内訳

収益と収入の歴史

フリー・キャッシュフローと収益の比較

過去の収益成長分析

株主資本利益率

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

過去基準チェック /46